Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles] “Controlled release-driven clinical benefits and next orientation” Editor:Shinji Sakuma
The development of drug delivery system for regulating mucosal immune system for future therapy of inflammatory bowel disease
Hiroshi Nakase, Tomoya Iida, Kei Onodera
Author information
Keywords: drug delivery system, microspheres, inflammatory bowel disease, cytokine, growth factor
JOURNAL FREE ACCESS

2016 Volume 31 Issue 3 Pages 194-200

Details
Download PDF (767K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract

Considering the pathophysiology of inflammatory bowel disease (IBD), it would be ideal to develop drug delivery system (DDS) regulating mucosal immune system as therapeutic strategy for IBD.Development of DDS with polymeric materials such as biodegradable microspheres, which could carry drugs, anti-inflammatory cytokines and growth factors to targeted gastrointestinal tracts, would contribute to future treatment for IBD.

Content from these authors
© 2016 The Japan Society of Drug Delivery System
Previous article Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top